Literature DB >> 21612462

Eculizumab in severe Shiga-toxin-associated HUS.

Anne-Laure Lapeyraque, Michal Malina, Véronique Fremeaux-Bacchi, Tobias Boppel, Michael Kirschfink, Mehdi Oualha, François Proulx, Marie-José Clermont, Françoise Le Deist, Patrick Niaudet, Franz Schaefer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21612462     DOI： 10.1056/NEJMc1100859

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  137 in total

Review 1.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

2.  Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.

Authors:  Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-12-13       Impact factor: 3.714

Review 3.  [Thrombophilic states in intensive care medicine].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-28       Impact factor: 0.840

4.  E. coli crisis opens door for Alexion drug trial.

Authors:  Lucas Laursen
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

5.  Advance modern medicine with clinical case reports.

Authors:  Yì-Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2014-12

Review 6.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

Review 7.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

Review 8.  A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Authors:  Sonata Jodele; Benjamin L Laskin; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Stella M Davies; Jens Goebel; Bradley P Dixon
Journal:  Blood Rev       Date:  2014-11-28       Impact factor: 8.250

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.

Authors:  F Semsa Cayci; Nilgun Cakar; Veysel Sabri Hancer; Nermin Uncu; Banu Acar; Gokce Gur
Journal:  Pediatr Nephrol       Date:  2012-08-19       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.